Related Experiment Video

Updated: Jul 4, 2026

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

Fluence to absorbed foetal dose conversion coefficients for photons in 50 keV-10 GeV calculated using RPI-P models

Valery Taranenko1, X George Xu

  • 1Nuclear Engineering and Engineering Physics Program, Rensselaer Polytechnic Institute, Room 1-11, NES Building, Tibbits Avenue, Troy, NY 12180, USA.

Radiation Protection Dosimetry
|June 4, 2008
PubMed

Radiation protection of pregnant females and the foetus against ionising radiation is of particular importance to radiation protection due to high foetal radiosensitivity. The only available set of foetal conversion coefficients for photons is based on stylised models of simplified anatomy. Using the RPI-P series of pregnant female and foetus models representing 3-, 6- and 9-month gestation, a set of new fluence to absorbed foetal dose conversion coefficients has been calculated. The RPI-P anatomical models were developed using novel 3D geometry modelling techniques. Organ masses were adjusted to agree within 1% with the ICRP reference data for a pregnant female. Monte Carlo dose calculations were carried out using the MCNPX and Penelope codes for external 50 keV-10 GeV photon beams of six standard configurations. The models were voxelised at 3-mm voxel resolution. Conversion coefficients were tabulated for the three gestational periods for the whole foetus and brain. Comparison with previously published data showed deviations up to 120% for the foetal doses at 50 keV. The discrepancy can be primarily ascribed to anatomical differences. Comparison with published data for five major mother organs is also provided for the 3-month model. Since the RPI-P models exhibit a high degree of anatomical realism, the reported dataset is recommended as a reference for radiation protection of the foetus against external photon exposure.

More Related Videos

Dosimetry for Cell Irradiation using Orthovoltage (40-300 kV) X-Ray Facilities06:51

Dosimetry for Cell Irradiation using Orthovoltage (40-300 kV) X-Ray Facilities

Published on: February 20, 2021

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

Related Concept Videos

Biological Effects of Radiation02:59

Biological Effects of Radiation

All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they produce ions...
Absorption of Radiation01:05

Absorption of Radiation

The rate of heat transfer by emitted radiation is described by the Stefan-Boltzmann law of radiation:
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
Measurement of Bioavailability: Pharmacodynamic Methods01:20

Measurement of Bioavailability: Pharmacodynamic Methods

Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
Pharmacodynamic Models: Linear Concentration–Effect Model01:15

Pharmacodynamic Models: Linear Concentration–Effect Model

The linear concentration–effect model, underpinned by the principle that pharmacological effect (E) is directly proportional to plasma drug concentration (C), emerges as a pivotal simplification of the Emax model for conditions where C is significantly less than EC50. This model portrays a linear trajectory of the concentration–effect relationship when drug levels are markedly below the EC50 threshold.Despite its inherent assumption of continuous effect augmentation with increasing drug...